Stifel Maintains Hold on Edwards Lifesciences, Lowers Price Target to $70
Portfolio Pulse from Benzinga Newsdesk
Stifel analyst Rick Wise has maintained a 'Hold' rating on Edwards Lifesciences (NYSE:EW) and lowered the price target from $87 to $70.
October 26, 2023 | 7:28 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Stifel analyst has maintained a 'Hold' rating on Edwards Lifesciences and lowered the price target from $87 to $70.
The lowering of the price target by Stifel analyst Rick Wise could potentially lead to a negative sentiment among investors, which may result in a short-term decrease in the stock price of Edwards Lifesciences.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100